Advisory Board and Editors Infectious Diseases
Morteza Saki
Dr. Morteza Saki is a researcher within the Department of Microbiology at the Ahvaz Jundishapur University of Medical Sciences,Ahvaz, Iran.
His research focuses on the mechanisms of antimicrobial resistance in ESKAPE Pathogens, especially Klebsiella pneumoniae.
Martina Schroeder
Dr Martina Schroeder is a Lecturer and Head of the Host-Pathogen Interaction Lab at Maynooth University. Her research addresses viral recognition, innate immune signaling pathways, and the roles of DEAD-box proteins in immunity. Previously Dr Schroeder conducted postdoctoral research with Prof. Andrew Bowie at Trinity College Dublin. In 2007, she was awarded a postdoctoral career development fellowship by the Irish HRB. She completed her PhD at the Charité University Hospital in Berlin in 2003.
Arif J Siddiqui
Dr. Arif Jamal Siddiqui is an Associate Professor and Principal Investigator at the Department of Biology, College of Science, University of Hail, Saudi Arabia. He received his PhD from CSIR-Central Drug Research Institute, Lucknow, India in 2015. From 2015 to 2018, he worked as a Post-Doctoral Fellow at Texas Tech University Health Sciences Center, Lubbock, Texas, United States of America.
He has more than 8 years of experience in research, teaching and administration. In his professional work, he has received research grants as a Principal Investigator from various renowned organizations. He has successfully published more than 100 publications in internationally recognized peer-reviewed prestigious journals, published several book chapters for internationally renowned publishers and presented many articles and posters in various conferences/workshops worldwide. He has published numerous papers in the fields of parasitology, immunology, herbal medicine, vaccine development, drug discovery and natural products with a specialization in anti-parasitic, antiviral, anticancer and antibacterial agents. Furthermore, he is a member of The Indian Science Congress Association, India and the Annals of Parasitology, Poland. He has reviewed more than 250 manuscripts and he also currently holds various editorial positions (Academic, Associate, Guest and Review Editor) in various reputable journals and has edited more than 150 manuscripts.
Joana C Silva
My group applies evolutionary genetics and genomic sciences to basic research on species evolution and translational research of infectious diseases. I have been studying infectious disease genomics since the early 2000's. At The Institute for Genomic Research (TIGR) I was part of the team that launched the field of parasite genomics, with work on several Plasmodium and trypanosomatid species, Theileria parva and Trichomonas vaginalis. At the Institute for Genome Sciences, University of Maryland School of Medicine, we have ongoing projects on a variety of parasites in the phylum Apicomplexa. These include the causative agents of malaria in humans (genus Plasmodium), tropical theileriosis and East Coast fever in cattle (genus Theileria), human babesiosis (genus Babesia), and human cryptosporidiosis (genus Cryptosporidium). Ongoing projects include the study of species biology and the nature of host-parasite interactions, based on the generation and analyses of genomes, and studies of vaccine efficacy and vaccine design, drug resistance and the evolution of parasite populations, informed by population genomics data. Our research is funded by NSF, NIH, USDA and the Bill and Melinda Gates Foundation.
Rajesh Kumar Singh
Dr. Rajesh Kumar Singh received his BPharm (2003) and MPharm (2005) from UIPS, Panjab University, Chandigarh. He started to teach pharmaceutical chemistry at the Shivalik College of Pharmacy, Nangal, in 2006, where he completed his PhD in 2013 from IKG Punjab Technical University (IKGPTU), Jalandhar. His major areas of research interest are computer-aided drug-design, polymer-drug conjugates for targeted delivery to CNS and cancerous cells, antimalarial therapeutic agents, and green chemistry approaches for chemical synthesis. Dr. Singh has over 15 years of teaching experience and has guided one 03 Ph.D. and 20 PG students. He is currently guiding 02 PhDs and 02 MPharm students. He has published more than 70 peer-reviewed SCI/SCOPUS-indexed scientific papers with a total JCR Impact Factor of more than 200 in various chemistry and pharmacy journals such as European Journal of Medicinal Chemistry, Acta Pharmaceutica Sinica-B, Bioorganic Chemistry, Biomedicine and Pharmacotherapy, Pharmaceutical Research, European Journal of Pharmaceutical Sciences, Mini-Reviews in Medicinal Chemistry, Pharmaceutical Research, Med. Chem. Res., J. Enzyme Inhi. Med Chem., Res. Chem. Intermediate etc as main or corresponding author. He currently serves as an Editorial Advisory Board Member of 10 international journals, including the SCI-indexed MRMC (Bentham) and PeerJ. He has received the Publon Award 2016, 2017 and the Publon "Excellent Peer Reviewer Award" for outstanding reviewing of more than 290 research papers in different international journals of ACS, RSC, Springer, Elsevier, Dove, Informa, and Bentham whose Impact Factor varies from 1.0 to 12.5. He also has over 60 National and International Conference Abstracts, 5 Books, 5 Best Paper Presentation Awards, 1 Travel Grant to attend International Conferences, and 5 Research Projects funded by Indian Government Agencies. He is also on the panel of international reviewers for research proposals for Royal Society Grants. He is also serving as a PUBLON ACADEMY MENTOR and a BENTHAM BRAND AMBASSADOR. He has been recognized by the Editors as an OUTSTANDING REVIEWER for RSC Medicinal Chemistry journal (IF 4.1, Q1) and also for BENTHAM PUBLISHER in 2023. His name is recently featured in the list of top 2% scientists (2023) ranked by team of Stanford University, USA and Elsevier.
Reema Singh
A highly accomplished Computational Biologist and Bioinformatician with over 19 years of research expertise. My professional focus is on One Health bioinformatics, using pathogen transcriptomics and genomic surveillance to investigate and control infectious threats and antimicrobial resistance. My career has been marked by a strong track record of developing impactful tools and pipelines, including the Dlact antimicrobial resistance gene database and the Gen2Epi computational pipeline. Currently, as a Bioinformatician and Data Manager at the Vaccine and Infectious Disease Organization (VIDO), I apply my skills to analyze large-scale transcriptomics data and elucidate host-pathogen interactions in both human and animal populations
Tara C. Smith
Professor of Epidemiology at Kent State University
Valeria Souza
Full professor at the Universidad Nacional Autónoma de México. Winner of several national conservation awards. Expert on microbial evolutionary ecology, works studying microbial mats and complex communities at Cuatro Ciénegas Coahuila, Mexico
Tim Stinear
Professor Tim Stinear is a Senior NHMRC Research Fellow and molecular microbiologist in the Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, University of Melbourne, Australia. He leads a bacterial pathogenesis research lab that focuses on using comparative and functional genomics to understand how certain bacteria evolve, spread and cause disease. In particular, his team studies pathogenic mycobacteria and hospital superbugs Staphylococcus aureus (Golden Staph) and Vancomycin Resistant Enterococci (VRE). He received his PhD in Microbiology from Monash University in 2001 followed by a 3-year postdoctoral period at the Institut Pasteur, Paris. He is a fellow of the Australian Society for Microbiology.
Xiaotian Tang
Dr. Xiaotian Tang is now an assistant professor (ZJU100 Young Professor) at Zhejiang University. He was a postdoctoral associate at Yale School of Medicine. His research interests include vector-borne diseases of animals and plants, and arthropod-pathogen-host interactions. He is also interested in evolutionary biology of arthropods.
He has over 40 publications in high-quality peer-reviewed journals, including Cell, PLOS Biology, eLife, Cell Reports, and Science Translational Medicine. He has served as academic or review editor for 4 journals and reviewer for over 20 journals.
Marc Tebruegge
Marc trained in Paediatrics and Paediatric Infectious Diseases in the UK (Great Ormond Street Hospital, St Mary's Hospital London), Germany, South Africa (University of Cape Town) and Australia (University of New South Wales). After 4 years of research into improved immunodiagnostics for childhood tuberculosis at the University of Melbourne and the Royal Children's Hospital Melbourne, he returned to the UK in 2011 as NIHR Academic Clinical Lecturer in Paediatric Infectious Diseases & Immunology.
Cindy Shuan Ju Teh
Associate Professor from the Universiti Malaya, Malaysia. As a microbiologist by training, Dr. Cindy is actively involved in antimicrobial resistance (AMR) research. She has been investigating the resistance mechanisms of multidrug resistance organisms (MDRO), the spread and persistence of MDRO in the hospital and community, as well as the effects of AMR on gut microbiome. More recently, she is also involved in behavioural psychology studies to determine the risk factors that accelerate AMR.
Since 2013, she has been the principal investigator of more than 40 projects funded by national and international funding bodies. She has accumulated more than 100 publications and graduated 18 postgraduate students